TY - JOUR
T1 - Quality of life and survival in patients with heart failure
AU - Hoekstra, T.
AU - Jaarsma, T.
AU - van Veldhuisen, D.J.
AU - Hillege, H.L.
AU - Sanderman, Robbert
AU - Lesman-Leegte, I.
PY - 2013
Y1 - 2013
N2 - A cohort of 661 patients (62% male; age 71 years; left ventricular ejection fraction 34%) was followed prospectively for 3 years. Quality of life questionnaires (Ladder of Life, RAND36, and Minnesota Living with Heart Failure Questionnaire) and BNP levels were assessed at discharge after a hospital admission for HF. Three-year mortality was 42%. After adjustment for demographic variables, clinical variables, and BNP levels, poor quality of life scores predicted higher mortality; per 10 units on the physical functioning [hazard ratio (HR) 1.08, 95% confidence interval (CI) 1.02–1.14] and general health (HR 1.08, 95% CI 1.01–1.16) dimensions of the RAND36. Patients with low scores on these dimensions were more likely to be in New York Heart Association class III–IV, diagnosed with co-morbidities, have suffered longer from HF, have lower estimated glomerular filtration rates, and have fewer beta-blocker prescriptions.
AB - A cohort of 661 patients (62% male; age 71 years; left ventricular ejection fraction 34%) was followed prospectively for 3 years. Quality of life questionnaires (Ladder of Life, RAND36, and Minnesota Living with Heart Failure Questionnaire) and BNP levels were assessed at discharge after a hospital admission for HF. Three-year mortality was 42%. After adjustment for demographic variables, clinical variables, and BNP levels, poor quality of life scores predicted higher mortality; per 10 units on the physical functioning [hazard ratio (HR) 1.08, 95% confidence interval (CI) 1.02–1.14] and general health (HR 1.08, 95% CI 1.01–1.16) dimensions of the RAND36. Patients with low scores on these dimensions were more likely to be in New York Heart Association class III–IV, diagnosed with co-morbidities, have suffered longer from HF, have lower estimated glomerular filtration rates, and have fewer beta-blocker prescriptions.
KW - METIS-304977
KW - IR-91704
U2 - 10.1093/eurjhf/hfs148
DO - 10.1093/eurjhf/hfs148
M3 - Article
SN - 1388-9842
VL - 15
SP - 94
EP - 102
JO - European Journal of Heart Failure
JF - European Journal of Heart Failure
IS - 1
ER -